Olistico Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$372K Hold
13,050
– – 0.16% 79
2026
Q2
$314K Hold
13,050
– – 0.13% 89
2026
Q1
$366K Buy
13,050
+12,500
+2,273% +$333K 0.18% 74
2025
Q4
$13.7K Buy
+550
New +$13.9K 0.01% 238
2025
Q3
– Sell
-650
Closed -$15.8K – 269
2025
Q2
$15.8K Sell
650
-7,460
-92% -$174K 0.01% 242
2025
Q1
$206K Buy
8,110
+7,610
+1,522% +$199K 0.13% 97
2024
Q4
$13.3K Hold
500
– – 0.01% 230
2024
Q3
$14.5K Sell
500
-396
-44% -$11.6K 0.01% 227
2024
Q2
$25.1K Buy
+896
New +$24.7K 0.02% 202
2023
Q3
– Sell
-6,385
Closed -$234K – 109
2023
Q2
$234K Buy
+6,385
New +$249K 0.2% 101

Other funds holding PFE

Olistico Wealth's PFE Position: Q3 2026 in Review

Olistico Wealth held its Pfizer (PFE) position steady in Q3 2026 at 13,050 shares worth $372K. The position accounts for 0.16% of the portfolio, ranked #79.

Olistico Wealth first reported a position in PFE in Q2 2023 and has held it in 10 quarters since. 718 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Olistico Wealth held 13,050 shares of Pfizer worth $372K as of Q3 2026.
  • Olistico Wealth left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.16% of Olistico Wealth's portfolio in Q3 2026, its #79 holding.
  • Olistico Wealth first reported a position in Pfizer in Q2 2023 and has held it in 10 quarters since.
  • 718 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Olistico Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.